Chieko Inoue
Director/Board Member chez ARK Resource Co. Ltd.
Profil
Chieko Inoue is currently a Director at ARK Resource Co. Ltd.
She was previously a Senior Managing Director at Happiness & D Co., Ltd.
from 2005 to 2008.
Postes actifs de Chieko Inoue
| Sociétés | Poste | Début |
|---|---|---|
ARK Resource Co. Ltd.
 ARK Resource Co. Ltd. BiotechnologyHealth Technology ARK Resource Co. Ltd. is a Japanese company that specializes in the manufacturing of monoclonal and polyclonal antibodies, fertilized eggs in mouse/rats, and culture used for reproductive engineering. ARK Resource Co. was founded in 1966 and is based in Kumamoto, Japan, with headquarters located at 383-2 Nakahara-cho, Nishi-ku, Kumamoto-shi, Kumamoto. The company offers a wide range of services from units to g units, including the supply of mouse monoclonal antibodies by ascelonus method and culture method. The company also provides a quick diagnostic genetic modified animal breeding colony by the service introduction pcr method, performing homo / hetero / wild type screening (geno typing). The company can identify specific disease bacteria in biological samples and culture cells. | Director/Board Member | - |
Anciens postes connus de Chieko Inoue
| Sociétés | Poste | Fin |
|---|---|---|
| HAPPINESS AND D CO.,LTD. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HAPPINESS AND D CO.,LTD. | Retail Trade |
| Entreprise privées | 1 |
|---|---|
ARK Resource Co. Ltd.
ARK Resource Co. Ltd. BiotechnologyHealth Technology ARK Resource Co. Ltd. is a Japanese company that specializes in the manufacturing of monoclonal and polyclonal antibodies, fertilized eggs in mouse/rats, and culture used for reproductive engineering. ARK Resource Co. was founded in 1966 and is based in Kumamoto, Japan, with headquarters located at 383-2 Nakahara-cho, Nishi-ku, Kumamoto-shi, Kumamoto. The company offers a wide range of services from units to g units, including the supply of mouse monoclonal antibodies by ascelonus method and culture method. The company also provides a quick diagnostic genetic modified animal breeding colony by the service introduction pcr method, performing homo / hetero / wild type screening (geno typing). The company can identify specific disease bacteria in biological samples and culture cells. | Health Technology |
